CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | -20.7% | 61,667 | +20.7% | 0.00% | – |
| Q2 2022 | $92,000 | +9.5% | 51,102 | +23.0% | 0.00% | – |
| Q1 2022 | $84,000 | -36.4% | 41,540 | -15.0% | 0.00% | -100.0% |
| Q4 2021 | $132,000 | -55.9% | 48,890 | -27.0% | 0.00% | 0.0% |
| Q3 2021 | $299,000 | -19.2% | 66,975 | +5.0% | 0.00% | -50.0% |
| Q2 2021 | $370,000 | +72.9% | 63,790 | +108.8% | 0.00% | +100.0% |
| Q1 2021 | $214,000 | +197.2% | 30,547 | +169.0% | 0.00% | 0.0% |
| Q1 2020 | $72,000 | – | 11,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |